Breaking News

You are here » Indian-Commodity  :  Commodities  :  Natural Rubber Costs Change Poor On Purchasers Resistance

12-May2011

Natural Rubber Costs Change Poor On Purchasers Resistance

Physical rubber costs dropped on Wednesday monitoring the weakness in local and worldwide commodities. Purchaser challenge guided the costs lower however there were no marketing stress from traders or farmers.The spotty rainfall during previous month have caused a spurt in rubber output in April.

The spot rates for RSS-4 type shut at Rs 231.00 in comparison to their last finishing of Rs 232.00, while RSS-5 range finished the same at Rs 229.00.

In the commodities marketplace, the settlement of May collection for RSS 4 decreased to Rs 228.40 from their past ending of Rs229.38, as the settlement for June supply finished at Rs 233.70 in comparison with their prior ending of Rs 235.43 on National MCX .

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......